Kathrine T Isaksen

Years Active: 2020-2023
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Ivana Spasevska, Ankush Sharma, Chloé Beate Steen, Sarah E Josefsson, Yngvild Nuvin Blaker, Arne Kolstad, Even Holth Rustad, Saskia Meyer, Kathrine T Isaksen, Stalin Chellappa, Kushi Kushekhar, Klaus Beiske, Mette S Førsund, Signe Spetalen, Harald Holte, Bjorn Ostenstad, Marianne Brodtkorb, Eva K Kimby, Johanna Olweus, Kjetil Taskén, Aaron M Newman, Susanne Lorenz, Erlend B Smeland, Ash A Alizadeh, Kanutte Huse, June Helen Myklebust
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood advances (2023)
Kathrine T Isaksen, Maria Adele Mastroianni, Marit Rinde, Leiv Sindre Rusten, Dlawer Abdulla Barzenje, Lloyd Frode Ramslien, Marit Slaaen, Marianne Brenn Jerm, Erlend B Smeland, Siri Rostoft, Knut Liestøl, Marianne Brodtkorb, Harald Holte
A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL. Blood advances 5 (22) (2021)
Kathrine T Isaksen, Klaus Beiske, Erlend B Smeland, Judit Jørgensen, Marianne Brodtkorb, June Helen Myklebust, Mats Jerkeman, Leo Meriranta, Marja-Liisa Karjalainen-Lindsberg, Sirpa Leppä, David W Scott, Harald Holte, Yngvild Nuvin Blaker
The DLBCL90 gene-expression assay identifies double-hit lymphomas with high sensitivity in patients from two phase II clinical trials with high-risk diffuse large B-cell lymphoma. EJHaem 2 (1) (2020)

Kathrine T Isaksen.css-eqlu8i{font-size:small;padding-left:4px;}